Skip to Content

JACOBUS 25 102 (Dapsone 25 mg)

Pill with imprint JACOBUS 25 102 is White, Round and has been identified as Dapsone 25 mg. It is supplied by Jacobus Pharmaceutical Company.

Dapsone is used in the treatment of dermatitis herpetiformis; bullous pemphigoid; leprosy; leprosy, lepromatous; leprosy, tuberculoid (and more), and belongs to the drug class leprostatics. Risk cannot be ruled out during pregnancy. Dapsone 25 mg is not a controlled substance under the Controlled Substance Act (CSA).

Images for JACOBUS 25 102

Dapsone 25 mg JACOBUS 25 102
Dapsone 25 mg JACOBUS 25 102
Dapsone 25 mg JACOBUS 25 102 Front
Dapsone 25 mg JACOBUS 25 102 Back
Dapsone 25 mg JACOBUS 25 102


JACOBUS 25 102
25 mg
6.00 mm
Prescription only
Drug Class:
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Jacobus Pharmaceutical Company
Inactive Ingredients:
silicon dioxide
magnesium stearate
microcrystalline cellulose
corn starch
Note: Inactive ingredients may vary.

Other Labelers / Repackagers:

NDC CodeLabeler / Repackager
13925-0504 Seton Pharmaceuticals LLC
55289-0188 PDRX Pharmaceuticals Inc. (repackager)
54868-2817 Physicians Total Care Inc. (repackager)

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2018, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.